<DOC>
	<DOCNO>NCT00900523</DOCNO>
	<brief_summary>RATIONALE : Measuring amount prostaglandin metabolite urine sample study tissue sample laboratory patient ovarian cancer may help doctor identify learn biomarkers related ovarian cancer may help study cancer future . PURPOSE : This laboratory study measure amount prostaglandin metabolite urine sample patient ovarian cancer .</brief_summary>
	<brief_title>Prostaglandin Metabolite Urine Samples From Patients With Ovarian Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine level prostaglandin E_2 metabolite ( PGE-M ) 24-hour urine sample collect prior surgery chemotherapy patient ovarian cancer . - Determine cyclooxygenase-1 ( COX-1 ) cyclooxygenase-2 ( COX-2 ) expression western blot immunohistochemistry ( IHC ) ovarian tumor tissue sample match normal ovarian tissue sample , available , patient . - Correlate urine PGE-M level correspond tissue COX-1 COX-2 level urine tissue sample patient . OUTLINE : This pilot study . Patients submit 24-hour urine specimens prior surgery evaluation urinary level prostaglandin E_2 metabolite ( PGE-M ) . Patients also undergo assessment tissue obtain time surgery , include ovarian tumor tissue , normal surface ovarian epithelium tissue ( available ) , fix tissue embed paraffin block . Tissue sample analyze western blot IHC cyclooxygenase-1 cyclooxygenase-2 expression .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>Diagnosis know suspected ovarian cancer Age great 17 year Pregnant nursing Taking steroid nonsteroidal antiinflammatory drug ( NSAIDs ) regular basis . PRIOR CONCURRENT THERAPY : No concurrent chronic use steroid NSAIDs</criteria>
	<gender>Female</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>recurrent ovarian epithelial cancer</keyword>
	<keyword>stage I ovarian epithelial cancer</keyword>
	<keyword>stage II ovarian epithelial cancer</keyword>
	<keyword>stage III ovarian epithelial cancer</keyword>
	<keyword>stage IV ovarian epithelial cancer</keyword>
</DOC>